It is now almost three decades since John Lawrence became the first to investigate the biological effects of the then new and strange subatomic particles being produced at the cyclotron in Berkeley, Calif. In the intervening years, these studies have been pursued with vision and imagination by the Berkeley investigators. Elsewhere in this issue of The Journal (p 236), Lawrence, Tobias, and their colleagues present the results of some of their biological experiments. They discuss the role of heavy-particle irradiation in medical research and treatment, and review their own clinical experience with this form of therapy. Certain features of protons and alpha particles make them especially interesting to the medical investigator and clinician. High-velocity heavy particles do not scatter readily in their passage through matter and produce intense excitation and ionization along their path. They give off energy in small amounts until, as their velocities approach zero, the ionization density
JAMA – American Medical Association
Published: Oct 19, 1963
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera